Michael Moore Sells 31,570 Shares of Viemed Healthcare (NASDAQ:VMD) Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) President Michael Moore sold 31,570 shares of the firm’s stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $9.42, for a total value of $297,389.40. Following the completion of the sale, the president directly owned 1,691,044 shares of the company’s stock, valued at $15,929,634.48. This represents a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Michael Moore also recently made the following trade(s):

• On Friday, March 20th, Michael Moore sold 65,000 shares of Viemed Healthcare stock. The shares were sold at an average price of $8.77, for a total value of $570,050.00.
• On Thursday, March 19th, Michael Moore sold 40,232 shares of Viemed Healthcare stock. The shares were sold at an average price of $9.21, for a total value of $370,536.72.

Viemed Healthcare Stock Down 5.5%

VMD stock opened at $8.71 on Friday. The stock has a fifty day moving average of $8.30 and a 200-day moving average of $7.37. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $10.06. The company has a market capitalization of $336.21 million, a price-to-earnings ratio of 23.54 and a beta of 1.23. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.06 and a current ratio of 1.18.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.02. The business had revenue of $76.18 million for the quarter, compared to analysts’ expectations of $77.70 million. Viemed Healthcare had a return on equity of 10.72% and a net margin of 5.53%.

Wall Street Analysts Forecast Growth

VMD has been the topic of a number of recent research reports. Wall Street Zen upgraded shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 14th. Zacks Research upgraded shares of Viemed Healthcare to a “hold” rating in a research note on Thursday, January 8th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Viemed Healthcare in a report on Monday, December 29th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. State of Alaska Department of Revenue bought a new position in shares of Viemed Healthcare in the fourth quarter worth approximately $25,000. Kemnay Advisory Services Inc. bought a new stake in Viemed Healthcare during the fourth quarter valued at approximately $46,000. Quarry LP purchased a new position in Viemed Healthcare in the 3rd quarter worth approximately $48,000. AQR Capital Management LLC purchased a new position in Viemed Healthcare in the 1st quarter worth approximately $90,000. Finally, SG Americas Securities LLC bought a new position in shares of Viemed Healthcare in the 4th quarter worth $101,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.